2012-10-24 12:27:48 -
Human growth hormone drugs market dominated by the US due to an emergence of approved products
The human growth hormone drugs market has been forecast to reach a market value of $4.7 billion by the year 2018, with the industry being predominantly driven by the high prevalence of growth hormone deficiency, improved delivery devices, development of novel drug delivery methods, and increasing indications of growth hormones.Human growth hormones are a naturally occurring protein hormone produced by the pituitary gland and are important for normal human growth and development, especially in children and teenagers. Low human growth hormone levels in children and teenagers result in dwarfism. Excessive human growth hormone levels increase muscle mass by stimulating protein synthesis, strengthen bones by stimulating bone growth and reduce body fat by stimulating the breakdown of fat cells. Use of
human growth hormone drugs has become increasingly popular as they are so difficult to detect.Human growth hormone products cater to two different markets - the vanity market and the treatment of growth hormone deficiency. Products targeting the vanity market are non-prescription drugs, which are primarily targeted for use in adults to enhance physical performance or in checking the aging process. On the other side, prescription human growth hormone products are targeted for use in both adults and children, mainly for the treatment of growth hormone deficiency.Excessive human growth hormones in the body can cause acromegaly, a disease where the hands become spade-like in appearance as they get bigger. Growth of the facial bones causes the face to change shape too. Organs like the heart, liver and kidneys will also undergo excessive growth, leading to potentially life-threatening problems - one of which is cardiomyopathy, a disease of the heart muscle.The US represents the largest region within the global human growth hormone drugs market. Demand for human growth hormone products began to surge in the US after the US FDA began granting approvals for new human growth hormone products. The emergence of approved products, especially for specific indications, led to a substantial increase in the number of patients diagnosed with these conditions.For more information on the human growth hormone drugs market, see the latest research: Human Growth Hormone Drugs MarketFollow us on Twitter @CandMResearch
Click for news details:
www.companiesandmarkets.com/News/Healthcare-and-Medical/Human-gr ..
Browse all Healthcare and Medical C&M News
www.companiesandmarkets.com/News/Healthcare-and-Medical/?aCode=f ..
About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.
